The Advanced Medical Technology Assn. today unveiled a new 3-year, 3-prong strategy for overcoming the "significant regulatory and economic challenges facing the industry."
New AdvaMed chairman and Zimmer (NYSE:ZMH) president & CEO David Dvorak highlighted the initiatives that will be the focus of his 2-year term: